“Risperidone versus quetiapine: risk of developing metabolic syndromes in patients suffering from psychiatry disorders of a health care center”, AJPHS, vol. 10, no. 3, pp. 2309–2317, Sep. 2020, doi: 10.5530/1a3vgq24.